Virology Specimen Collection Market: Rising Prevalence of Viral Diseases and Emergence of Newer Pathogens are Boosting the Growth

Growth in the Virology Specimen Collection Market is mainly driven by the rising prevalence of viral diseases, the increasing prevalence of human papillomavirus (HPV) and cervical cancer. Rising number of blood donations are among the factors boosting the growth of the market. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the virology specimen collection market.



The rising prevalence of viral diseases such as SARS-CoV-2, AIDS, flu, EBOLA, Zika virus, and STDs is a major factor driving the demand for effective virology specimen collection. According to the WHO (July 2021), there were an estimated 37.7 million (30.2–45.1 million) people living with HIV at the end of 2020, over two-thirds of whom (25.4 million) lived in the WHO African Region. In 2020, 680,000 (480 000–1.0 million) people died from HIV-related causes, and 1.5 million (1.0–2.0 million) people acquired HIV. In addition, according to the WHO (July 2021), globally, there were an estimated 7 million new syphilis infections in 2020. This is expected further to drive the demand for virology specimen collection market.
read more..